PMD Psychemedics Corporation
Healthcare$2.67+0.00%ClosedMarket Cap: $15.6M
As of 2026-05-25
Valuation
P/E (TTM)
—
PEG
—
P/B
3.05
P/S
0.79
EV/EBITDA
80.17
DCF Value
$1.90
FCF Yield
5.4%
Div Yield
0.0%
Margins & Returns
Gross Margin
36.1%
Operating Margin
-9.6%
Net Margin
-9.5%
ROE
-31.5%
ROA
-22.4%
ROIC
-29.2%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 null | $4.4M | 31.4% | $168.0K | $189.0K | $— | — |
| FY null | $19.7M | 36.1% | $-1.9M | $-1.9M | $— | — |
| Q3 null | $5.2M | 39.4% | $-595.0K | $-535.0K | $— | — |
| Q2 null | $4.7M | 32.8% | $-899.0K | $-827.0K | $— | — |
| Q1 null | $5.4M | 39.6% | $-567.0K | $-688.0K | $— | — |
| Q4 null | $5.0M | 41.2% | $-868.0K | $-945.0K | $— | — |
| FY null | $22.1M | 38.1% | $-2.9M | $-4.2M | $— | $0.14 |
| Q3 null | $5.7M | 36.7% | $-1.1M | $-2.1M | $— | — |
| Q2 null | $5.5M | 37.2% | $-417.0K | $-726.0K | $— | $0.14 |
| Q1 null | $5.9M | 37.6% | $-528.0K | $-384.0K | $— | $0.07 |
| Q4 2022 | $5.7M | 39.4% | $-356.0K | $-688.0K | $-0.12 | $0.07 |
| FY null | $25.2M | 36.8% | $-1.1M | $-1.1M | $— | $0.21 |